Significance of technology in diabetes care during pandemic in our county hospital

Al-Shaibany Azhar

doi:10.1530/endoabs.73.AEP808

Introduction

In last two decades, new technological advances have permitted the use of novel approaches to the management of diabetes. Continuous Glucose Monitoring (CGM) has been linked to improved HbA1c and overall quality of life. The evidence, however, is limited to retrospective studies. This audit was designed to evaluate the effectiveness and impact of CGM before and after on HbA1c and quality of life in clinical practice setting during pandemic in our county for 12 patients in our local Diabetes Day Centre (DDC).

Methods

Data of diabetes patients identified from medical notes of DDC in Our Lady’s hospital of Navan for patients commenced on DEXCOM CGM since we started using CGM in 2019. Total number of patients recruited for this audit is12. All patients have type I diabetes mean age of participant is 38 years for 10–12 months duration.

Patients Contacted by phones to answer the following questions:

- Frequency of hypoglycemia (<4 mmol) episodes before and after getting CGM?

- HbaA1C before and after CGM? Collected from our lab system.

- Lifestyle quality after getting CGM system?

- Satisfaction: Are patients satisfied with DEXCOM CGM (less hypoglycemia, less stress in diabetes control, more confidence)? With rating (0–10) Score.

Results

Among 12 patients with type I diabetes who were commenced on CGM, it shows:

• All patients have no or very little hypoglycemia after CGM with hypoglycemia confidence.

• 90% of patients had reduced overall HbA1c after CGM and less diabetes distress.

• All patients noted remarkable improvement in quality of life.

• All patients satisfied with CGM technology and more than half of patients have 100% satisfaction and others more than 80% satisfaction.

Figure 1 Satifaction score of patients on technology.

Figure 2 Average HbA1c pre and post CGM.

**Table 1** Hypoglycemia before and after, Hba1c before and after CGM
Number	Hypoglycemia before CGM	Hypoglycemia after CGM	HbAlc before CGM (mmol/mol)	HbAlc after CGM (mmol/mol)	Life quality after CGM	Satisfaction score 0–10
1	up to few limes aclay,	Twice a month	92	78	improved	7
2	up to 5 times a month	Nil	94	64	improved	10
3	Once a month	Once a month	74	70	Improved	10
4	Once a clay	Once a month	66	55	Improved	10
5	Tree times/clay	3 times/week	88	73	Improved	10
6	4 times/week	One time/week	66	58	improved	9
7	Once every week	Once every 3 months	80	64	improved	8
8	Up to 8 per week	Up to 2 per week	59	70	improved	10
9	Once per month	No hypoglycemia	113	91	improved	8
10	Almost every day	No Hypoglycemia	91	101	improved	10
11	Once per month	No hypoglycemia	85	70	improved	8
12	Once every week	No Hypoglycemia	50	Not done	improved

Conclusion

Obviously, it is highly recommended to consider CGM a common and useful tool in diabetes care who was at high risk of dysglycemia. It showed significant improvement in less time spent for day and nocturnal hypoglycemia. Patients feel safer and more confident during pandemic where the diabetes care facilities are very limited. It provided remarkable glycemic control and positive effects on HbA1c levels. Less dysglycemia, as a result, improved life quality.

Endocrine Abstracts

AEP808

Significance of technology in diabetes care during pandemic in our county hospital

Azhar Al-Shaibany

Volume 73

European Congress of Endocrinology 2021

Article tools

My recent searches

My recently viewed abstracts

Authors

BiosciAbstracts